Page last updated: 2024-08-21

8-aminoquinoline and Disease Models, Animal

8-aminoquinoline has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Flaherty, S; Maktabi, M; Pybus, BS; Reichard, G; Rochford, R; Strauch, P; Walker, LA1
Amnuaysirikul, J; Caridha, D; Gao, X; Grogl, M; Hickman, M; Ishida, H; Li, Q; Magill, AJ; O'Neil, MT; Ohrt, C; Ray, P; Weina, PJ; Zhang, P1
Cojean, S; Loiseau, PM; Schrével, J1
Ceccom, J; Coslédan, F; Francès, B; Halley, H; Lassalle, JM; Meunier, B1
Bartlett, MS; Berman, JD; Dean, RA; Ellis, WY; Milhous, WK; Queener, SF; Smith, JW1

Reviews

1 review(s) available for 8-aminoquinoline and Disease Models, Animal

ArticleYear
Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.
    Parasite (Paris, France), 2011, Volume: 18, Issue:2

    Topics: Administration, Oral; Aminoquinolines; Animals; Antiprotozoal Agents; Biological Availability; Disease Models, Animal; Drug Resistance; Humans; Leishmania; Leishmaniasis, Visceral

2011

Other Studies

4 other study(ies) available for 8-aminoquinoline and Disease Models, Animal

ArticleYear
Mechanisms of 8-aminoquinoline induced haemolytic toxicity in a G6PDd humanized mouse model.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:13

    Topics: Aminoquinolines; Animals; Antimalarials; Disease Models, Animal; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Malaria, Vivax; Mice; Primaquine

2022
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:6

    Topics: Acute Disease; Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Genotype; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Haptoglobins; Hemolytic Agents; Male; Mefloquine; Mice; Phenotype; Primaquine; Reticulocyte Count

2013
Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Animals; Chelating Agents; Cognition; Copper; Disease Models, Animal; Injections; Male; Memory, Episodic; Mice; Mice, Inbred C57BL; Peptide Fragments; Recovery of Function; Time Factors

2012
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
    The Journal of infectious diseases, 1992, Volume: 165, Issue:4

    Topics: Aminoquinolines; Animals; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Female; Pneumonia, Pneumocystis; Primaquine; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Trimethoprim, Sulfamethoxazole Drug Combination

1992